Chemoinformaics analysis of AURANTIAMIDE ACETATE
| Molecular Weight | 444.531 | nRot | 10 |
| Heavy Atom Molecular Weight | 416.307 | nRig | 21 |
| Exact Molecular Weight | 444.205 | nRing | 3 |
| Solubility: LogS | -4.418 | nHRing | 0 |
| Solubility: LogP | 3.62 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 3 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 18 |
| nHA | 4 | APOL | 69.1682 |
| nHD | 2 | BPOL | 33.5698 |
| QED | 0.47 |
| Synth | 2.692 |
| Natural Product Likeliness | 0.014 |
| NR-PPAR-gamma | 0.513 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.75 |
| Pgp-sub | 0.003 |
| HIA | 0.546 |
| CACO-2 | -4.971 |
| MDCK | 0.00015925 |
| BBB | 0.114 |
| PPB | 0.963161 |
| VDSS | 0.424 |
| FU | 0.0397572 |
| CYP1A2-inh | 0.331 |
| CYP1A2-sub | 0.055 |
| CYP2c19-inh | 0.875 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.938 |
| CYP2c9-sub | 0.156 |
| CYP2d6-inh | 0.351 |
| CYP2d6-sub | 0.273 |
| CYP3a4-inh | 0.923 |
| CYP3a4-sub | 0.509 |
| CL | 2.01 |
| T12 | 0.716 |
| hERG | 0.578 |
| Ames | 0.785 |
| ROA | 0.039 |
| SkinSen | 0.3 |
| Carcinogencity | 0.484 |
| EI | 0.009 |
| Respiratory | 0.009 |
| NR-Aromatase | 0.017 |
| Antiviral | Yes |
| Prediction | 0.662653 |